How costly is non-adherence to infliximab in patients with Crohn's disease?

J Med Econ. 2014 Dec;17(12):881-2. doi: 10.3111/13696998.2014.964406. Epub 2014 Sep 26.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antibodies, Monoclonal / economics*
  • Antibodies, Monoclonal / therapeutic use
  • Crohn Disease / drug therapy*
  • Gastrointestinal Agents / economics*
  • Gastrointestinal Agents / therapeutic use
  • Humans
  • Infliximab
  • Medication Adherence*

Substances

  • Antibodies, Monoclonal
  • Gastrointestinal Agents
  • Infliximab